Skip to main content

Peer Review reports

From: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Original Submission
12 Feb 2009 Submitted Original manuscript
17 Apr 2009 Reviewed Reviewer Report - Sophie Barillé-Nion
24 Apr 2009 Reviewed Reviewer Report - Jaafar Bennouna
11 May 2009 Reviewed Reviewer Report - Olivier Coqueret
8 Jun 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 2
8 Jun 2009 Submitted Manuscript version 2
11 Jun 2009 Reviewed Reviewer Report - Sophie Barillé-Nion
1 Jul 2009 Reviewed Reviewer Report - Olivier Coqueret
20 Jul 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 3
20 Jul 2009 Submitted Manuscript version 3
30 Jul 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 4
30 Jul 2009 Submitted Manuscript version 4
6 Aug 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 5
6 Aug 2009 Submitted Manuscript version 5
8 Sep 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 6
8 Sep 2009 Submitted Manuscript version 6
17 Sep 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 7
17 Sep 2009 Submitted Manuscript version 7
Publishing
18 Sep 2009 Editorially accepted
18 Sep 2009 Article published 10.1186/1471-2407-9-333

You can find further information about peer review here.

Back to article page